Last modified: January 10, 2010
Offices[edit]
People[edit]
Web Presences[edit]
- Biotech & Life Sciences
Industries[edit]
Parent Company[edit]
Acquisitions / Subsidiaries[edit]
Paid Sources[edit]
Keywords[edit]
|
|
Description[edit]
Company Profile
The Genetix Pharmaceuticals Mission is to develop and commercialize effective gene therapies for the treatment of serious, chronic human diseases. GENETIX has pioneered a curative therapy for hereditary blood disorders, currently in Phase I/II EU clinical trials. As published in Science and PNAS, LentiGlobin™ hemoglobin gene therapy has demonstrated 100% correction in animal models of sickle cell disease and thalassemia major, the two most prevalent human genetic disorders, with large orphan markets. GENETIX’ proprietary LentiGlobin™ vector is based on ten years of research at Harvard and MIT. GENETIX holds exclusive patents for lentiviral gene transfer, a critical therapeutic gene, and the only gene regulator capable of high level gene expression.
With encouraging preliminary Clinical Data, a clear path to commercialization, the potential to expand to additional high-value indications, an experienced team and committed US and European investors, Genetix Pharmaceuticals is positioned to bring to market the first curative therapy for hereditary blood disorders.
Innovation[edit]
Activities[edit]
| Jobs by SimplyHired |
- No jobs were found for this particular company. Please visit the job board to search for more.
| Genetix Pharmaceuticals Job Trends | Genetix Pharmaceuticals Jobs |
- Biotech Showcase 2010 - Presenting Companies (3 subscribers)
This Company is Being Watched in
Recent Updates |
|---|
| Genetix Pharmaceuticals has been added to the Ecosystem. |